+
JSW Group to procure vaccines for 25,000 employees and their families
ECONOMY & POLICY

JSW Group to procure vaccines for 25,000 employees and their families

As an initial step in the process of inoculating employees against Covid-19, JSW Group, a few Tata Group companies, the India unit of a major multinational, and numerous other firms have plans to begin talks with vaccine manufacturers. The employees working at manufacturing units are more vulnerable than those working from home, and will receive priority treatment.

The first shots of the vaccine will be available from as early as March. According to sources, around two to three lakh doses will be supplied. Serum Institute of India began delivering its Covishield vaccines last week, followed by Bharat Biotech with the homegrown Covaxin. The initial focus is to vaccinate healthcare and frontline professionals by July.

Tata Group said that some of the companies in the conglomerate have initiated discussions on procuring vaccines, but a decision hasn't been taken yet, as informed by sources.

The India unit of a multinational manufacturing company is awaiting communication from the parent, which has initiated talks with global vaccine manufacturers for its units in North America and Europe.

Instead of depending on Serum Institute and Bharat Biotech alone, companies are waiting for more vaccines to come into the market. Four other companies are in different stages of conducting trials including Russia's Sputnik vaccine that will be distributed by Dr Reddy's Lab in India, and Zydus Cadila, which recently got the nod for third phase trials.

As companies await better clarity on the supply of vaccines, some wonder whether vaccination of employees could be included under corporate social responsibility.

Image source

As an initial step in the process of inoculating employees against Covid-19, JSW Group, a few Tata Group companies, the India unit of a major multinational, and numerous other firms have plans to begin talks with vaccine manufacturers. The employees working at manufacturing units are more vulnerable than those working from home, and will receive priority treatment. The first shots of the vaccine will be available from as early as March. According to sources, around two to three lakh doses will be supplied. Serum Institute of India began delivering its Covishield vaccines last week, followed by Bharat Biotech with the homegrown Covaxin. The initial focus is to vaccinate healthcare and frontline professionals by July. Tata Group said that some of the companies in the conglomerate have initiated discussions on procuring vaccines, but a decision hasn't been taken yet, as informed by sources. The India unit of a multinational manufacturing company is awaiting communication from the parent, which has initiated talks with global vaccine manufacturers for its units in North America and Europe. Instead of depending on Serum Institute and Bharat Biotech alone, companies are waiting for more vaccines to come into the market. Four other companies are in different stages of conducting trials including Russia's Sputnik vaccine that will be distributed by Dr Reddy's Lab in India, and Zydus Cadila, which recently got the nod for third phase trials. As companies await better clarity on the supply of vaccines, some wonder whether vaccination of employees could be included under corporate social responsibility. Image source

Next Story
Resources

Hisense Opens First India Manufacturing Plant at Sri City

Hisense has inaugurated its first manufacturing facility in India at Sri City, Andhra Pradesh, through a joint venture with Epack Manufacturing Technologies Private Limited, a wholly owned subsidiary of Epack Durable Limited.The 10-acre facility, developed with an investment exceeding USD 30 million, is located within Epack Durable’s industrial park at Sri City and will commence commercial production from February 2026. Once fully operational, the plant will manufacture Room Air Conditioners (RACs) exclusively for Hisense India, accounting for 100 per cent of the brand’s domestic RAC outpu..

Next Story
Real Estate

Superb Realty Launches Altura, Focuses on IAQ-Led Office Design

Superb Realty has launched Superb Altura, a mixed-use Grade A commercial development at Amar Mahal junction in the Chembur–Ghatkopar corridor, positioning indoor air quality and intelligent building systems at the centre of its design strategy amid rising pollution levels in Mumbai.The development reflects a shift in office real estate priorities, where occupiers increasingly evaluate how buildings manage health, energy efficiency and operational resilience in high-pollution urban environments. Altura integrates advanced systems that continuously monitor and optimise indoor environments, cov..

Next Story
Infrastructure Transport

CPCL Tops NHAI’s First DPR Consultant Ranking

Chaitanya Projects Consultancy (CPCL) has secured the top position in the National Highways Authority of India’s first-ever provisional DPR consultants rating, achieving a score of 80.75 out of 100. The ranking places CPCL ahead of 55 peer firms, including Pentacle Consultants (78), L&T Infrastructure Engineering (76), MSV International Technology (74), and Transys Consulting (72).The rankings, released in the fourth week of January 2026, mark NHAI’s first structured and transparent evaluation of DPR consultants to improve quality standards under Bharatmala and other national highway p..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Open In App